A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ruxolitinib Impurity 18 - Request Quote

Picture of Ruxolitinib Impurity 18

Ruxolitinib Impurity 18

SZ CAT No:SZ-R044037
CAS No
NA
Mol.F.
C18H19N7O
Mol.Wt.
349.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ruxolitinib Impurity 18 is chemically (R)-4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine-7-carboxamide. Ruxolitinib Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ruxolitinib Impurity 18

Purchase Ruxolitinib Impurity 18

Ruxolitinib Impurity 18 suppliers

Ruxolitinib Impurity 18 manufacturers

Ruxolitinib Impurity 18 price

Order Ruxolitinib Impurity 18

Enquire Ruxolitinib Impurity 18

Ruxolitinib Impurity 18 cost

Ruxolitinib Impurity 18 Supplier

Ruxolitinib Impurity 18 Distributor

Ruxolitinib Impurity 18 for Method Validation

Ruxolitinib Reference Standard

Ruxolitinib Impurity 18 for ANDA Filing

Ruxolitinib Impurity 18 for Forced Degradation Studies

Ruxolitinib Impurity 18 Identification Standards

Ruxolitinib Impurity 18 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,